How is RFK Jr. reshaping US vaccine policy?
Policy moves and institutional changes
Since taking office, the health secretary has overseen a string of decisions that have altered the shape of federal vaccine policy. One early move removed several vaccines from the government’s universally recommended schedule. At the same time, routine functions of independent advisory bodies have been disrupted: meetings of the Centers for Disease Control and Prevention’s vaccine advisory panel were postponed or cancelled, and legal and administrative steps have called into question the future role of independent advisory groups.
Leadership and staffing shifts have compounded the uncertainty. Senior officials at federal public‑health agencies have resigned or been replaced, and an NIH director was named to take on temporary leadership at the CDC. These personnel changes, paired with policy moves, have prompted industry and scientific concern.
Effects on vaccine research, delivery, and public trust
The policy shifts have had immediate practical consequences: vaccine manufacturers and researchers report a chilling effect on investment and projects, with some firms curtailing vaccine research. Public‑health officials warn that changes to recommendation processes and advisory structures could undermine longstanding systems designed to evaluate safety and effectiveness independently.
Possible implications include:
- reduced private‑sector investment in vaccine development;
- slower or altered rollout of new or updated vaccines; and
- erosion of public confidence in immunisation advice if independent scientific review is perceived as compromised.
What remains unclear is how permanent these changes will be. Some actions—such as updates to the recommended schedule or the structure of advisory committees—can be reversed or modified by future administrations or through legal and administrative processes. For now, the combined effect is a period of instability in U.S. vaccine policy that public‑health experts say raises the risk of gaps in protection and could complicate responses to outbreaks.